SC 13G
SC 13G Filing
- Company
- Biodexa Pharmaceuticals Plc
- Filed
- August 8, 2024
- Accession Number
- 0000930413-24-002268
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →